MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced it has reached 18,000 implantations of its Endoskeleton® interbody fusion devices since its inception and is rapidly approaching a $20 million annualized sales revenue run-rate. These two achievements reflect the continuing rapid surgeon adoption of its proprietary interbody fusion devices and mark a paradigm shift toward devices engineered with roughened titanium surface technology.
Help employers find you! Check out all the jobs and post your resume.
